The nurse is planning care for a child in the acute phase of Kawasaki disease. Which intervention is priority?

Choice A rationale Antibiotics are ineffective as Kawasaki disease is an acute systemic vasculitis, not a bacterial infection, making them inappropriate. Corticosteroids are reserved for patients refractory to initial treatment or with specific complications due to potential side effects and limited evidence of benefit in the acute phase, thus not the immediate priority. Choice B rationale Antipyretics, such as acetaminophen, manage fever and discomfort but do not address the underlying systemic inflammation and risk of coronary artery aneurysms. Antihistamines are generally unnecessary unless pruritus or an allergic reaction is present, and they are not central to preventing cardiac complications in this critical phase. Choice C rationale Intravenous fluids are important to maintain hydration, especially with prolonged fever, but they are not the definitive treatment for preventing long-term cardiac damage. Morphine is an opioid analgesic, which is typically not required for the pain associated with Kawasaki disease, making it a low priority. Choice D rationale Intravenous Immune Globulin (IVIG), 2 g/kg infused over 10-12 hours, is the cornerstone of acute treatment, reducing inflammation and the risk of coronary artery aneurysm formation. High-dose aspirin (80-100 mg/kg/day divided every 6 hours) is used for its anti-inflammatory properties during the acute, febrile phase.